CN204246685U - The intellectual drug the worn guiding structure that electrolyte position is fixing - Google Patents
The intellectual drug the worn guiding structure that electrolyte position is fixing Download PDFInfo
- Publication number
- CN204246685U CN204246685U CN201420641563.4U CN201420641563U CN204246685U CN 204246685 U CN204246685 U CN 204246685U CN 201420641563 U CN201420641563 U CN 201420641563U CN 204246685 U CN204246685 U CN 204246685U
- Authority
- CN
- China
- Prior art keywords
- storage vault
- electrode
- opening
- guiding structure
- vault
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Electrotherapy Devices (AREA)
Abstract
The intellectual drug the worn guiding structure that this utility model provides a kind of electrolyte position fixing, comprises power supply, medicine bag structure, storage vault, and electrode structure.This utility model by the temporally precise of the dosage of ionized medication and conduction and accurately can control, and reduces and avoids drug percutaneous to conduct uncontrollable dosage.In this utility model, multiple medicine can be preserved in a storage vault or multiple storage vault, can at one time or be transmitted in body in the different time by one or more power supply; And multiple medicine is preserved and can be avoided the reaction between medicine and mutually disturb in multiple storage vault; Can not also need to adopt transdermal enhancer, reduce the stimulation to skin.
Description
Technical field
This utility model relates to the fixing intellectual drug the worn guiding structure in a kind of electrolyte position.
Background technology
Medicine provides therapeutic effect to different diseases, usually maybe must must keep medicine at certain concentration level to reach therapeutic effect the best at certain time administration or certain temporal mode administration.Unfortunately patient is usually less than interval or period take medicine as requested.And oral drugs affect due to the highly acidity environment of stomach or the first pass effect of liver, can cause part or all of inefficacy.
In order to overcome these problems, medicine can pass through percutaneous drug delivery.Common is with syringe or continuous drip injection various dose medicine without intestinal canal administration method.May be improper for these methods long-term treatment patient, because the injury repeatedly of pinprick and intravenous drip device understand the freedom of action of limiting patient, also bring misery to patient.
A kind of more comfortable drug administrating device passes through Epidermal administration.In the traditional Chinese medical science field of China, the application of this plaster or plaster and extensively.With the administration of plaster mode usually in a period of time (as one day to one week), when without the need to the administration of patient's initiative, provide the administration of continuing dosage.Daily use is applicable to being had by the medicine of percutaneous drug delivery: nicotine, hormone and some analgesic (as fentanyl).Its application comprises, for the Nicotine patch of giving up smoking; Low-level estrogen and the plaster of progestogen for practising contraception is discharged to skin by continuous.This Epidermal administration device is portable, comfortable and be very applicable to patient to pinprick fear.Had by the major advantage of Epidermal administration: provide continuing dosage by design rate of release; Avoid the impact of the first pass effect oral disposition medicine of gastrointestinal tract and liver; Noinvasive; Without the need to patient's insertion administration, but patient also can administration at any time or drug withdrawal.But its advantage is also its shortcoming for some medicines: owing to maintaining the continued for constant dosage in body, just cause drug resistance and the Drug resistance of body or disease; Some physiological functions of human body or pathological phenomenon are obvious circadian rhythm, administration should change according to the daily rhythmicity in the processes such as the bioavailability of medicine, blood drug level, metabolism and excretion, continued for constant dosage can affect the treatment on the contrary, and produces untoward reaction and side effect.
It is a kind of physical process by ion flow diffusion under additional electric field media drive that electron ion oozes therapy, makes the ion drug class of solubility enter health under the function of current, thus reaches therapeutic purposes.Before the device that electron ion oozes therapy starts from 1900 the earliest.1934, one section of British patent (410,009) describe an electron ion and ooze therapeutic apparatus, manufacture formation and comprise: multiple electrode and the raw material containing therapeutic component or medicine that can be penetrated by percutaneous, and an accumulator providing ion-transmission to transmit medicine institute energy requirement.This device is accepted the impact of patient's daily life owing to decreasing administration, is the realization of early stage electron ion infiltration administration.Recently, United States Patent (USP) has delivered the correlation technique that electron ion oozes therapy, shows that this method has the interest of renewal for medicine conduction, the patent U.S. Pat. No. 7,844,327 of the people such as such as Anderson; The patent U.S. Pat. No. 7,945,320 of Durand; The patent U.S. Pat. No. 8,386,030 of the people such as Kananmura; The patent U.S. Pat. No. 8,463,373 of Anderson; The patent U.S. Pat. No. 8,666,486 etc. of Dombdisclose lists electron ion permeability apparatus and some application.
Usually in Iontophoretic device, at least use two electrodes, direct and contact skin, and wait use transdermal enhancer in use, very large for skin lesion.An electrode, active electrode, acts on chemical substance by electric power, compound, medicament, or medicine, makes it transmit or enters in body.Another is antielectrode.Two electrodes together with power supply, form a closed voltage or current loop with skin.Such as: a medicine ion is positive electrical polarity (positive charge ion), so anelectrode (anode) is exactly form a closed-loop path between active electrode and antielectrode (negative electrode).If medicine ion is with negative charge, so negative electrode is active electrode, and anelectrode is antielectrode.The most outstanding iontophoretic advantage is the control to medicine conductive quantity and time.
Summary of the invention
The technical problems to be solved in the utility model, is the intellectual drug the worn guiding structure providing a kind of electrolyte position fixing, user-friendly.
This utility model is achieved in that the intellectual drug the worn guiding structure that a kind of electrolyte position is fixing, comprise medicine bag structure and the first power supply, the first storage vault and the second storage vault is provided with in described medicine bag structure, described second storage vault is annular, described first storage vault is located in described second storage vault annular, the first electrode is provided with in described first storage vault, described first storage vault one side is provided with the first opening, described first opening part is provided with first and thoroughly releases film, gel medicinal liquid is full of in described first storage vault, the second electrode is provided with in described second storage vault, described second storage vault one side is provided with the second opening, described second opening part is provided with second and thoroughly releases film, gel electrolyte is full of in described second storage vault, the both positive and negative polarity of described first power supply connects described first electrode and the second electrode respectively.
Further, described first opening is relative with described first electrode, and described second opening is relative with described second electrode.
Further, the spacing of described first storage vault and described second storage vault is greater than 10mm.
Further, described first opening part is provided with first and thoroughly releases film, and described second opening part is provided with second and thoroughly releases film.
Further, described gelatinous drug is detachably located in described first storage vault, and described gel electrolyte is detachably located in described second storage vault.
Further, also comprise at least one the 3rd storage vault, each described 3rd apotheca is located in described second storage vault annular, the 3rd electrode is provided with in each described 3rd storage vault, each described 3rd storage vault one side is provided with the 3rd opening, described 3rd opening part is provided with the 3rd and thoroughly releases film, is full of gel medicinal liquid in each described 3rd storage vault, and described first power supply is connected to each described 3rd electrode.
Further, described 3rd opening is relative with described 3rd electrode.
Further, also comprise at least one the 4th storage vault, with its second source and one the 5th storage vault one to one, each described 4th storage vault is located in described second storage vault annular, in each described 4th storage vault, a side is provided with the 4th opening, each described 4th opening part is provided with the 4th and thoroughly releases film, gel medicinal liquid is full of in each described 4th storage vault, in each described 4th storage vault, a side is provided with the 4th electrode, described 5th storage vault is located in described second storage vault annular, described 5th storage vault one side is provided with the 5th opening, described 5th opening part is provided with the 5th and thoroughly releases film, gel electrolyte is full of in described 5th storage vault, described 5th storage vault one side is provided with the 5th electrode, each described second source connects the 4th electrode described in one and the 5th electrode respectively.
Further, described 4th electrode is relative with described 4th opening, and described 5th electrode is relative with described 5th opening.
Further, described first storage vault, the 3rd storage vault and the 4th storage vault surround a ring-shape, and described 5th storage vault is located in described ring-shape.
This utility model tool has the following advantages: the intellectual drug the worn guiding structure that this utility model electrolyte position is fixing, the time of the dosage of ionized medication and conduction can be controlled exactly and accurately; The dosage diffusing through skin of this utility model and contact skin medicine, far below the dosage of iontophoresis through skin, makes drug percutaneous conduct uncontrollable dosage and minimizes or be avoided; In this utility model, multiple medicine can be preserved in a storage vault or multiple storage vault, can at one time or be transmitted in body in the different time by one or more power supply; And multiple medicine is preserved and can be avoided the reaction between medicine and mutually disturb in multiple storage vault; Can not also need to adopt transdermal enhancer, skin irritation is reduced.
Accompanying drawing explanation
This utility model is further described with reference to the accompanying drawings in conjunction with the embodiments.
Fig. 1 is the structural representation of this utility model embodiment one.
Fig. 2 is the sectional view of this utility model embodiment one.
Fig. 3 is the structural representation of this utility model embodiment two.
Fig. 4 is the structural representation of this utility model embodiment three.
Detailed description of the invention
The intellectual drug the worn guiding structure that this utility model electrolyte position is fixing, comprise medicine bag structure and the first power supply, the first storage vault and the second storage vault is provided with in described medicine bag structure, described second storage vault is annular, described first storage vault is located in described second storage vault annular, the first electrode is provided with in described first storage vault, described first storage vault one side is provided with the first opening, described first opening part is provided with first and thoroughly releases film, gel medicinal liquid is full of in described first storage vault, the second electrode is provided with in described second storage vault, described second storage vault one side is provided with the second opening, described second opening part is provided with second and thoroughly releases film, gel electrolyte is full of in described second storage vault, the both positive and negative polarity of described first power supply connects described first electrode and the second electrode respectively, described first opening is relative with described first electrode, described second opening is relative with described second electrode, the spacing of described first storage vault and described second storage vault is greater than 10mm, described gelatinous drug is detachably located in described first storage vault, described gel electrolyte is detachably located in described second storage vault.。
This utility model also comprises at least one the 3rd storage vault, each described 3rd apotheca is located in described second storage vault annular, the 3rd electrode is provided with in each described 3rd storage vault, each described 3rd storage vault one side is provided with the 3rd opening, described 3rd opening part is provided with the 3rd and thoroughly releases film, be full of gel medicinal liquid in each described 3rd storage vault, described first power supply is connected to each described 3rd electrode, and described 3rd opening is relative with described 3rd electrode.
This utility model also comprises at least one the 4th storage vault, with its second source and one the 5th storage vault one to one, each described 4th storage vault is located in described second storage vault annular, in each described 4th storage vault, a side is provided with the 4th opening, each described 4th opening part is provided with the 4th and thoroughly releases film, gel medicinal liquid is full of in each described 4th storage vault, in each described 4th storage vault, a side is provided with the 4th electrode, described 5th storage vault is located in described second storage vault annular, described 5th storage vault one side is provided with the 5th opening, described 5th opening part is provided with the 5th and thoroughly releases film, gel electrolyte is full of in described 5th storage vault, described 5th storage vault one side is provided with the 5th electrode, each described second source connects the 4th electrode described in one and the 5th electrode respectively, described 4th electrode is relative with described 4th opening, described 5th electrode is relative with described 5th opening, described first storage vault, 3rd storage vault and the 4th storage vault surround a ring-shape, described 5th storage vault is located in described ring-shape.
Wherein said first releases film, second thoroughly thoroughly releases film, each 3rd and thoroughly releases film, each 4th and thoroughly release film and the 5th thoroughly to release film be protective layer; medicine ion is transmitted to skin by above-mentioned film of thoroughly releasing; or also can be called penetrating film, form membrane structure by the uniform small pores of certain pore size.
In order to more detailed explanation this utility model, be further described by reference to the accompanying drawings, as follows:
As Fig. 1 and Fig. 2 illustrates according to the first embodiment of the present utility model.The intellectual drug the worn guiding structure 100 that this utility model electrolyte position is fixed is made up of a circular medicine bag structure 101 and the first power supply (not marking in figure), be made up of circular first storage vault 103 and annular second storage vault 102 in circular medicine bag structure 101, one first electrode 106 is provided with in described first storage vault 103, one second electrode 105 is provided with in second storage vault 102, as shown in Figure 2, first electrode 106 and the second electrode 105 are installed in the roof of each storage vault, the bottom of described first storage vault 103 is provided with first and thoroughly releases film (not shown), the bottom of described second storage vault 102 is provided with second and thoroughly releases film (not shown), first power supply can be used to the first electrode 106 in the first storage vault 103 and the second electrode 105 in the second storage vault 102.
Medicine bag structure 101 part can obtain with plastics or silicone rubber.The size of the intellectual drug the worn guiding structure 100 that this utility model electrolyte position is fixed is diameter 75mm, high 6mm, but other sizes also can be used.The diameter 20mm of the first storage vault 103, high 3mm.Second storage vault 102 can be internal diameter 40mm, external diameter 45mm, and high 3mm's is circular, and other sizes also can use.The bottom area of this second storage vault 102 and the first storage vault 103 ensures identical as far as possible, and the distance L between the second storage vault 102 and the first storage vault 103 should ensure to be greater than 10mm, to ensure that electric current can be dispersed on skin uniformly.
For the medicament of carbonium, gelatinous ionized medication can be stored in the first storage vault 103.And the gel in the second storage vault 102 can be the gel only comprising electrolytic ion.The positive power source terminal of the first power supply just puts on the first electrode 106 in the first storage vault 103, the negative power end of the first power supply puts on the second electrode 105 at the second storage vault 102, when after the first power initiation, in the first storage vault 103, the agent of carbonium chemical medicine is just thoroughly released the skin that film is sent to below it from the first storage vault 103 through first under Coulomb force effect, passes in body through skin.Meanwhile, just can according to dosage ionized medication be passed in body by the intensity of the output current or voltage that control the first power supply.
The medicament of carbonium and the medicament of negative ion can be mixed to form gel medicinal liquid with gel-type vehicle, are stored in respectively in the first storage vault 103 or the second storage vault 102.The gel-type vehicle of reference can be organogel, hydrogel, and in addition, hydroxyethyl-cellulose can mix with gel-type vehicle, but other gel-type vehicle also can use.
In the design of medicine bag constructional device body 100, the position of corresponding first storage vault 102 and the second storage vault 103 can be cavity structure.Gel electrolyte and gelatinous drug can be made into the size and shape with the first storage vault 102 and second its corresponding cavity structure of storage vault 103, and gel electrolyte and gelatinous drug just can be put into wherein.Like this, gel electrolyte and gelatinous drug can be replaced, and medicine bag constructional device body 100 can be accomplished to wear intellectual drug gatherer one.
As shown in Figure 3, for the second specific embodiment of the present utility model, the intellectual drug the worn guiding structure 210 that this utility model electrolyte position is fixed includes medicine bag constructional device 211, first power supply (not marking in figure), first storage vault 213, 3rd storage vault 214, 4th storage vault 215 and the 5th storage vault 216, and the second storage vault 212 of an annular, first storage vault 213 top is provided with the first electrode (not shown), the bottom of the first storage vault 213 is provided with the first opening (not shown), described first opening part is provided with first and thoroughly releases film (not shown), 3rd storage vault 214 top is provided with the 3rd electrode (not shown), and the bottom of the 3rd storage vault 214 is provided with the 3rd opening (not shown), and described 3rd opening part is provided with the 3rd and thoroughly releases film (not shown), 4th storage vault 215 top is provided with the 4th electrode (not shown), and the bottom of the 4th storage vault 215 is provided with the 4th opening (not shown), and described 4th opening part is provided with the 4th and thoroughly releases film (not shown), 5th storage vault 216 top is provided with the 5th electrode (not shown), and the bottom of the 5th storage vault 216 is provided with the 5th opening (not shown), and described 5th opening part is provided with the 5th and thoroughly releases film (not shown), second storage vault 212 top is provided with the second electrode (not shown), and the bottom of the second storage vault 212 is provided with the second opening (not shown), and described second opening part is provided with second and thoroughly releases film (not shown), the intellectual drug the worn guiding structure 210 that this utility model electrolyte position is fixed is applicable to the administration of four kinds of medicaments, different medicaments is put into the first storage vault 213, the 3rd storage vault 214, the 4th storage vault 215 and the 5th storage vault 216, between the electrode putting on the first storage vault 213, the 3rd storage vault 214, the 4th storage vault 215 and the 5th storage vault 216 by the first power supply and the electrode of the second storage vault 212, realize the transdermal administration of four kinds of medicaments simultaneously, or put between the first storage vault 213 and the electrode of the second storage vault 212, between the 3rd storage vault 214 and the electrode of the second storage vault 212, between the 4th storage vault 215 and the electrode of the second storage vault 212 respectively by multiple power supply, with the 5th between storage vault 216 and the electrode of the second storage vault 212, the transdermal administration of four kinds of medicaments when realizing different.
As shown in Figure 4, the third specific embodiment of the present utility model, the intellectual drug the worn guiding structure 220 that this utility model electrolyte position is fixing, comprise the first power supply (not marking in figure), first storage vault 223, 3rd storage vault 224, 4th storage vault 225 and the 5th storage vault 226, and the second storage vault 222 of an annular and a central repository 227, first storage vault 223 top is provided with the first electrode (not shown), the bottom of the first storage vault 223 is provided with the first opening (not shown), described first opening part is provided with first and thoroughly releases film (not shown), 3rd storage vault 224 top is provided with the 3rd electrode (not shown), and the bottom of the 3rd storage vault 224 is provided with the 3rd opening (not shown), and described 3rd opening part is provided with the 3rd and thoroughly releases film (not shown), 4th storage vault 225 top is provided with the 4th electrode (not shown), and the bottom of the 4th storage vault 225 is provided with the 4th opening (not shown), and described 4th opening part is provided with the 4th and thoroughly releases film (not shown), 5th storage vault 226 top is provided with the 5th electrode (not shown), and the bottom of the 5th storage vault 226 is provided with the 5th opening (not shown), and described 5th opening part is provided with the 5th and thoroughly releases film (not shown), second storage vault 222 top is provided with the second electrode (not shown), and the bottom of the second storage vault 222 is provided with the second opening (not shown), and described second opening part is provided with second and thoroughly releases film (not shown), in order to make electric current evenly the region being distributed under the intellectual drug the worn guiding structure fixed electrolyte position in, the intellectual drug the worn guiding structure 220 that electrolyte position is fixed also comprises a central repository 227, the top of described central repository 227 is provided with the 6th electrode (not shown), the bottom of described central repository 227 is provided with the 6th opening (not shown), and described 6th opening part is provided with the 6th and thoroughly releases film (not shown).Four kinds of medicaments can be placed in four storage vaults 223,224,225 and 226 respectively in this embodiment.Also comprise second source (not shown), 3rd power supply (not shown) and the 4th power supply (not shown), first power supply connects the first electrode and the second electrode respectively, second source connects the 4th electrode and the second electrode respectively, 3rd power supply connects the 3rd electrode and the 6th electrode respectively, 4th power supply connects the 5th electrode and the 6th electrode respectively, by the first power supply, second source, the switch of the 3rd power supply and the 4th power supply can realize four kinds of medicaments simultaneously or asynchronous transdermal administration, the intellectual drug the worn guiding structure 220 that this utility model electrolyte position is fixed is applicable to the administration of four kinds of medicaments, different medicaments is put into the first storage vault 223, 3rd storage vault 224, 4th storage vault 225 and the 5th storage vault 226, the first storage vault 213 is put on by the first power supply, 3rd storage vault 214, between the electrode of the 4th storage vault 215 and the 5th storage vault 216 and the electrode of the second storage vault 222 and central repository 227, realize the transdermal administration of four kinds of medicaments simultaneously, or put on respectively between the first storage vault 223 and the electrode of the second storage vault 222, between the 3rd storage vault 224 and the electrode of the second storage vault 222, between the 4th storage vault 225 and the electrode of central repository 227 by multiple power supply, with the 5th between storage vault 226 and the electrode of central repository 227, the transdermal administration of four kinds of medicaments when realizing different.
This utility model tool has the following advantages: the intellectual drug the worn guiding structure that this utility model electrolyte position is fixing, the time of the dosage of ionized medication and conduction can be controlled exactly and accurately; The dosage diffusing through skin of this utility model and contact skin medicine, far below the dosage of iontophoresis through skin, makes drug percutaneous conduct uncontrollable dosage and minimizes or be avoided; In this utility model, multiple medicine can be preserved in a storage vault or multiple storage vault, can at one time or be transmitted in body in the different time by one or more power supply; And multiple medicine is preserved and can be avoided the reaction between medicine and mutually disturb in multiple storage vault; Can not also need to adopt transdermal enhancer, skin irritation is reduced.
Although the foregoing describe detailed description of the invention of the present utility model; but be familiar with those skilled in the art to be to be understood that; specific embodiment described by us is illustrative; instead of for the restriction to scope of the present utility model; those of ordinary skill in the art, in the modification of the equivalence done according to spirit of the present utility model and change, should be encompassed in scope that claim of the present utility model protects.
Claims (10)
1. the intellectual drug the worn guiding structure that an electrolyte position is fixing, it is characterized in that: comprise medicine bag structure and the first power supply, the first storage vault and the second storage vault is provided with in described medicine bag structure, described second storage vault is annular, described first storage vault is located in described second storage vault annular, the first electrode is provided with in described first storage vault, described first storage vault one side is provided with the first opening, gel medicinal liquid is full of in described first storage vault, the second electrode is provided with in described second storage vault, described second storage vault one side is provided with the second opening, gel electrolyte is full of in described second storage vault, the both positive and negative polarity of described first power supply connects described first electrode and the second electrode respectively.
2. the intellectual drug the worn guiding structure that electrolyte position according to claim 1 is fixing, it is characterized in that: described first opening is relative with described first electrode, described second opening is relative with described second electrode.
3. the intellectual drug the worn guiding structure that electrolyte position according to claim 1 is fixing, it is characterized in that: described first opening part is provided with first and thoroughly releases film, described second opening part is provided with second and thoroughly releases film.
4. the intellectual drug the worn guiding structure that electrolyte position according to claim 1 is fixing, is characterized in that: the spacing of described first storage vault and described second storage vault is greater than 10mm.
5. according to claim 1ly wear intellectual drug guiding structure, it is characterized in that: described gelatinous drug is detachably located in described first storage vault, and described gel electrolyte is detachably located in described second storage vault.
6. the intellectual drug the worn guiding structure that electrolyte position according to claim 1 is fixing, it is characterized in that: also comprise at least one the 3rd storage vault, each described 3rd apotheca is located in described second storage vault annular, the 3rd electrode is provided with in each described 3rd storage vault, each described 3rd storage vault one side is provided with the 3rd opening, described 3rd opening part is provided with the 3rd and thoroughly releases film, be full of gel medicinal liquid in each described 3rd storage vault, described first power supply is connected to each described 3rd electrode.
7. the intellectual drug the worn guiding structure that electrolyte position according to claim 6 is fixing, is characterized in that: described 3rd opening is relative with described 3rd electrode.
8. the intellectual drug the worn guiding structure that electrolyte position according to claim 6 is fixing, it is characterized in that: also comprise at least one the 4th storage vault, with its second source and one the 5th storage vault one to one, each described 4th storage vault is located in described second storage vault annular, in each described 4th storage vault, a side is provided with the 4th opening, each described 4th opening part is provided with the 4th and thoroughly releases film, gel medicinal liquid is full of in each described 4th storage vault, in each described 4th storage vault, a side is provided with the 4th electrode, described 5th storage vault is located in described second storage vault annular, described 5th storage vault one side is provided with the 5th opening, described 5th opening part is provided with the 5th and thoroughly releases film, gel electrolyte is full of in described 5th storage vault, described 5th storage vault one side is provided with the 5th electrode, each described second source connects the 4th electrode described in one and the 5th electrode respectively.
9. the intellectual drug the worn guiding structure that electrolyte position according to claim 8 is fixing, it is characterized in that: described 4th electrode is relative with described 4th opening, described 5th electrode is relative with described 5th opening.
10. the intellectual drug the worn guiding structure that electrolyte position according to claim 8 is fixing, it is characterized in that: described first storage vault, the 3rd storage vault and the 4th storage vault surround a ring-shape, described 5th storage vault is located in described ring-shape.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420641563.4U CN204246685U (en) | 2014-10-31 | 2014-10-31 | The intellectual drug the worn guiding structure that electrolyte position is fixing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420641563.4U CN204246685U (en) | 2014-10-31 | 2014-10-31 | The intellectual drug the worn guiding structure that electrolyte position is fixing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204246685U true CN204246685U (en) | 2015-04-08 |
Family
ID=52951044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420641563.4U Active CN204246685U (en) | 2014-10-31 | 2014-10-31 | The intellectual drug the worn guiding structure that electrolyte position is fixing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204246685U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104353183A (en) * | 2014-10-31 | 2015-02-18 | 厦门微科格瑞生物科技有限公司 | Wearable intelligent medicine induction structure with fixedly positioned electrolyte |
-
2014
- 2014-10-31 CN CN201420641563.4U patent/CN204246685U/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104353183A (en) * | 2014-10-31 | 2015-02-18 | 厦门微科格瑞生物科技有限公司 | Wearable intelligent medicine induction structure with fixedly positioned electrolyte |
| WO2016066050A1 (en) * | 2014-10-31 | 2016-05-06 | 厦门微科格瑞生物科技有限公司 | Wearable smart drug-delivery system |
| CN104353183B (en) * | 2014-10-31 | 2016-12-07 | 厦门微科格瑞生物科技有限公司 | The wearable intellectual drug guiding structure that electrolyte position is fixing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10172997B2 (en) | Implantable solid-liquid drug delivery apparatus, formulations, and methods of use | |
| KR950008027B1 (en) | Iontotherapeutic device and unit dose | |
| KR100994631B1 (en) | Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis | |
| JP2002541935A (en) | Electrically driven delivery system with internal sensor | |
| JPS6335266A (en) | Apparatus for administration of drug by iontophoresis | |
| CN104368084B (en) | Wearable intellectual drug import system | |
| CN104353183B (en) | The wearable intellectual drug guiding structure that electrolyte position is fixing | |
| US11511095B2 (en) | Portable transdermal administration patch apparatus and preparation method thereof | |
| US7885708B2 (en) | Iontophoresis device | |
| Subramony | Needle free parenteral drug delivery: Leveraging active transdermal technologies for pediatric use | |
| JP2015211904A (en) | Electrode pad for iontophoresis | |
| CN208641537U (en) | A kind of transdermal delivery device | |
| RU2017113354A (en) | INJECTION MICROPARTICLES FOR SUPERLOCALIZED RELEASE OF THERAPEUTIC MEDICINES | |
| JPWO2007010900A1 (en) | Patch for percutaneous absorption with ion position display function and iontophoresis device | |
| RU2485982C1 (en) | Device and methods for improved multiple per os delivery of biologically active substances and for prevention of local irritation | |
| CN204246683U (en) | Intellectual drug import system can be worn | |
| CN204246685U (en) | The intellectual drug the worn guiding structure that electrolyte position is fixing | |
| CN204246684U (en) | One can wear intellectual drug gatherer | |
| CN110841134A (en) | Automatic drug delivery system for treating Parkinson's disease | |
| CN104353182B (en) | A kind of wearable intellectual drug gatherer | |
| CN210044690U (en) | Novel drug administration leading-in device | |
| CN207832613U (en) | A kind of novel intelligent is transdermal and oral administration equipment | |
| WO2019157833A1 (en) | Novel smart transdermal and oral administration equipment and method | |
| CN116035800B (en) | Subcutaneous implantation type repeated administration device through semicircular canal inner ear | |
| Li et al. | Drug delivery using electrophoresis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210623 Address after: 361000 8a57, 1036 Xiahe Road, Siming District, Xiamen City, Fujian Province Patentee after: Xiamen Lianfu Shangqi Information Consulting Co.,Ltd. Address before: 361000 unit 213, 2 / F, building 6, 2879 Dongfu Avenue, Haicang District, Xiamen City, Fujian Province Patentee before: XIAMEN MICROTECH BIOSCIENCES Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220720 Address after: 361000 room 1802, South Building, Ruida international finance building, No. 18 Taoyuan Road, Siming District, Xiamen City, Fujian Province Patentee after: Xiamen Jingfan Biotechnology Co.,Ltd. Address before: 361000 8a57, 1036 Xiahe Road, Siming District, Xiamen City, Fujian Province Patentee before: Xiamen Lianfu Shangqi Information Consulting Co.,Ltd. |